Omzo GLP-1 Review Verdict (June 2026): Final Assessment for Buyers Ready to Decide Quick Answer: Omzo is a structurally sound, cash-pay telehealth platform with transparent Terms, a three-entity clinical-platform-pharmacy model, and strong compounded medication disclosures
Over time, clinicians may increase the dose based on treatment response and tolerability
Cost considerations Pharmaceutical semaglutide (Wegovy): $1,300-1,500/month without insurance Insurance may cover (varies) Patient assistance programs available Research semaglutide: $150-300/month No insurance No patient assistance User assumes risk Research cagrilintide: $200-400/month Not prescription available yet Higher cost due to limited availability Total CagriSema combination cost (research chemicals): $350-700/month Both peptides at full dose Significant investment Compare to bariatric surgery ($15,000-25,000 upfront) Budget planning: Year 1 (titration + maintenance): $4,200-8,400 Ongoing maintenance: $350-700/month Consider reducing to maintenance doses May need 12-24+ months total Use our peptide cost calculator to budget protocols
Draw the prescribed volume carefully
With a Mounjaro coupon from SingleCare, you could pay as low as $875 at CVS pharmacy instead, depending on your pharmacy and location
These sites have been specifically validated through clinical trials to ensure consistent drug absorption, with no clinically meaningful differences in exposure observed between injection sites
